|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Horizon Therapeutics (NASDAQ: HZNP) through any online brokerage.
The latest price target for Horizon Therapeutics (NASDAQ: HZNP) was reported by Morgan Stanley on March 22, 2021. The analyst firm set a price target for 103.00 expecting HZNP to rise to within 12 months (a possible 0.38% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Horizon Therapeutics (NASDAQ: HZNP) is $102.61 last updated Thu Jul 29 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Horizon Therapeutics.
There is no upcoming split for Horizon Therapeutics.
Horizon Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.